Scott A. Gangloff SEC EDGAR Filings (CIK 0001663253)

SEC EDGAR filings, ownership reports, and insider transactions for Scott A. Gangloff.

Business address
C/O Akero Therapeutics, 601 Gateway Blvd #350, South San Francisco, CA, 94080
Get insider transactions for this reporting owner
Scott A. Gangloff has filed 10 SEC EDGAR filings since 12 May 2016

Latest Filings

Recent SEC filings for Scott A. Gangloff including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 09 Dec 2025 09 Dec 2025 001-38944
4 Open 4 document View SEC filing for 4 4 19 Aug 2025 15 Aug 2025 001-38944
4 Open 4 document View SEC filing for 4 4 02 Jul 2025 30 Jun 2025 001-38944
4 Open 4 document View SEC filing for 4 4 20 Jun 2025 18 Jun 2025 001-38944
4 Open 4 document View SEC filing for 4 4 18 Dec 2024 16 Dec 2024 001-38944
4 Open 4 document View SEC filing for 4 4 01 May 2024 29 Apr 2024 001-38944
3 Open 3 document View SEC filing for 3 3 01 May 2024 29 Apr 2024 001-38944
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Dec 2016 21 Dec 2016 001-37759
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 14 Nov 2016 09 Nov 2016 001-37759
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 12 May 2016 12 May 2016 001-37759

About this filer

Scott A. Gangloff files with the SEC under CIK 0001663253. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages